Respiri Ltd
ASX:RSH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.022
0.096
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Respiri Ltd
Other Equity
Respiri Ltd
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
R
|
Respiri Ltd
ASX:RSH
|
Other Equity
-AU$44.1k
|
CAGR 3-Years
50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
20%
|
|
|
ImpediMed Ltd
ASX:IPD
|
Other Equity
AU$8.3m
|
CAGR 3-Years
20%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Other Equity
-AU$1.3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-1%
|
|
|
Cochlear Ltd
ASX:COH
|
Other Equity
-AU$52.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Respiri Ltd
Glance View
Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-07-14. The firm's segments include Australia and Israel. The Australia segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Israel. The firm has developed a wheezo, which is an eHealth Saas platform that uses a device and app to measure, record and assist asthma monitoring. Its device and app make up a cloud-based mobile health platform that records wheeze and other clinically relevant symptoms and signs of asthma.
See Also
What is Respiri Ltd's Other Equity?
Other Equity
-44.1k
AUD
Based on the financial report for Jun 30, 2024, Respiri Ltd's Other Equity amounts to -44.1k AUD.
What is Respiri Ltd's Other Equity growth rate?
Other Equity CAGR 10Y
20%
Over the last year, the Other Equity growth was -7 911%. The average annual Other Equity growth rates for Respiri Ltd have been 50% over the past three years , and 20% over the past ten years .
You don't have any saved screeners yet
